Nicotinamide adenine dinucleotide phosphate oxidase (NOX) is widely expressed in brain tissue including neurons, glia, and endothelia in neurovascular units. It is a major source of oxidants in the post-ischemic brain and significantly contributes to ischemic brain damage. Inflammation occurs after brain ischemia and is known to be associated with post-ischemic oxidative stress. Post-ischemic inflammation also causes progressive brain injury. In this study we investigated the role of NOX2 in post-ischemic cerebral inflammation using a transient middle cerebral artery occlusion model in mice. We demonstrate that mice with NOX2 subunit gp91 phox knockout (gp91 KO) showed 35-44% less brain infarction at 1 and 3 days of reperfusion compared with wild-type (WT) mice. Minocycline further reduced brain damage in the gp91 KO mice at 3 days of reperfusion. The gp91 KO mice exhibited less severe post-ischemic inflammation in the brain, as evidenced by reduced microglial activation and decreased upregulation of inflammation mediators, including interleukin-1β (IL-1β), tumor necrosis factor-α, inducible nitric oxide synthases, CC-chemokine ligand 2, and CC-chemokine ligand 3. Finally, we demonstrated that an intraventricular injection of IL-1β enhanced ischemia-and reperfusion-mediated brain damage in the WT mice (double the infarction volume), whereas, it failed to aggravate brain infarction in the gp91 KO mice. Taken together, these results demonstrate the involvement of NOX2 in post-ischemic neuroinflammation and that NOX2 inhibition provides neuroprotection against inflammatory cytokine-mediated brain damage.
Introduction
Stroke ranks third among all causes of death in the US and it is the most common cause of severe morbidity (AHA statistics 2010 http:// www.americanheart.org/ downloadable/heart/1265665152970DS-3241% 20Heart StrokeUpdate_2010.pdf). Transient ischemic stroke is characterized by initial ischemia in the brain, followed by reperfusion. Various pathophysiological processes occur during stroke and they contribute to brain damage in a temporal manner. Shortly after ischemia, because of the insufficient supply of oxygen and glucose, cells rapidly develop energy failure and membrane depolarization, and are unable to maintain intracellular ion homeostasis, which may result in cell damage (Lipton, 1999) . Substantial amounts of reactive oxygen species (ROS) are generated in the brain as early as at 1 h of reperfusion (Murakami et al., 1998) . ROS-mediated oxidative stress significantly induces further damage in the ischemic brain (Chan, 1996 (Chan, , 2001 .
ROS were robustly generated by pro-oxidant enzyme activity and by mitochondria after cerebral ischemia-reperfusion (I/R) (Chan, 2001) . Nicotinamide adenine dinucleotide phosphate oxidase (NOX) is an important pro-oxidant protein in the brain (Bedard and Krause, 2007) . It catalyzes the generation of superoxide anions (O 2 • − ), which are major precursors of ROS (Bedard and Krause, 2007) . gp91 phox is the catalytic subunit of NOX2, and gp91 phox knockout (gp91 KO) mice, which are deficient in NOX2 activity, have been produced (Pollock et al., 1995) . Our previous study demonstrated that gp91 phox ablation significantly alleviated ROS generation and lipid and DNA oxidative damage after cerebral ischemia (Chen et al., 2009 ). After stroke, brain damage continues in the penumbra region and usually takes several days to mature (Lipton, 1999) . It has been postulated that the delayed brain damage may be due to the cerebral inflammation process that occurs in response to the initial ischemic brain insult (Barone and Feuerstein, 1999; Wang et al., 2007) . Cerebral inflammation is characterized by microglia activation, peripheral monocytes, and neutrophil infiltration and the upregulation of inflammatory mediators including cytokines and chemokines (Wang et al., 2007) . Microglia are the main immune cells in the , superoxide anion; ONOO−, peroxynitrite; NF-κB, nuclear factor κ-B; PBS, phosphate-buffered saline; PCR, polymerase chain reaction; QPCR, quantitative real-time polymerase chain reaction; ROS, reactive oxygen species; TNFα, tumor necrosis factor-α; TRAF6, tumor necrosis factor receptor-associated factor 6; WT, wild-type; 3-NT, 3-nitrotyrosine.
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